|
| Human KIR2DL5 Protein (LTP10229) |
|
| LTP10229 |
|
| 100ug |
|
|
$450 In stock |
| A recently developed anti-KIR2DL5 (CD158f) antibody has demonstrated KIR2DL5 expression on the surface of NK and T lymphocytes, making it the last functional KIR identified in the human genome. KIR2DL5 belongs to an ancestral lineage of KIR with Ig-like domains of the D0-D2 type, of which KIR2DL4, an HLA-G receptor, is the only other human member. |
| Recombinant Human KIR2DL5 Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal. It contains His22-His240. |
|
| KIR2DL5 |
|
| Human |
|
| NP_065396 |
|
| His22-His240 |
|
| The protein has a predicted MW of 26.3 kDa. Due to glycosylation, the protein migrates to 45-52 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-His-Avi |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
